Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 2
2005 4
2006 6
2007 7
2008 8
2009 1
2011 2
2012 4
2013 6
2014 4
2015 8
2016 7
2017 8
2018 6
2019 11
2020 18
2021 21
2022 21
2023 18
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Results by year

Filters applied: . Clear all
Page 1
AML in the elderly-A global view.
Hokland P, Fernández II, Freeman SD, Gjertsen BT, Jin J, Murthy V, Yanada M, Ganser A. Hokland P, et al. Among authors: yanada m. Br J Haematol. 2023 Dec;203(5):760-773. doi: 10.1111/bjh.19135. Epub 2023 Oct 11. Br J Haematol. 2023. PMID: 37822071 Review. No abstract available.
FLT3-targeted treatment for acute myeloid leukemia.
Arai Y, Chi S, Minami Y, Yanada M. Arai Y, et al. Among authors: yanada m. Int J Hematol. 2022 Sep;116(3):351-363. doi: 10.1007/s12185-022-03374-0. Epub 2022 May 9. Int J Hematol. 2022. PMID: 35532877 Review.
Acute myeloid leukemia in older adults.
Yanada M, Naoe T. Yanada M, et al. Int J Hematol. 2012 Aug;96(2):186-93. doi: 10.1007/s12185-012-1137-3. Epub 2012 Jul 13. Int J Hematol. 2012. PMID: 22791510 Review.
Mutated KIT Tyrosine Kinase as a Novel Molecular Target in Acute Myeloid Leukemia.
Katagiri S, Chi S, Minami Y, Fukushima K, Shibayama H, Hosono N, Yamauchi T, Morishita T, Kondo T, Yanada M, Yamamoto K, Kuroda J, Usuki K, Akahane D, Gotoh A. Katagiri S, et al. Among authors: yanada m. Int J Mol Sci. 2022 Apr 23;23(9):4694. doi: 10.3390/ijms23094694. Int J Mol Sci. 2022. PMID: 35563085 Free PMC article. Review.
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.
Akahoshi Y, Nakasone H, Takenaka K, Yamasaki S, Nakamura M, Doki N, Tanaka M, Ozawa Y, Uchida N, Ara T, Nakamae H, Ota S, Onizuka M, Yano S, Tanaka J, Fukuda T, Kanda Y, Atsuta Y, Kako S, Yanada M, Arai Y. Akahoshi Y, et al. Among authors: yanada m. Blood Adv. 2023 Jun 27;7(12):2699-2708. doi: 10.1182/bloodadvances.2022009376. Blood Adv. 2023. PMID: 36661335 Free PMC article.
Prognostic impact of complex and/or monosomal karyotypes in post-transplant poor cytogenetic acute myeloid leukaemia: A quantitative approach.
Jo T, Arai Y, Oshima S, Kondo T, Harada K, Uchida N, Doki N, Fukuda T, Tanaka M, Ozawa Y, Kuriyama T, Ikegame K, Katayama Y, Ota S, Ara T, Kawakita T, Onizuka M, Ichinohe T, Atsuta Y, Yanada M; Japanese Society for Transplantation and Cellular Therapy (JSTCT). Jo T, et al. Among authors: yanada m. Br J Haematol. 2023 Jul;202(2):356-368. doi: 10.1111/bjh.18855. Epub 2023 May 21. Br J Haematol. 2023. PMID: 37211753 Free article.
Clinical significance of FLT3 in leukemia.
Kiyoi H, Yanada M, Ozekia K. Kiyoi H, et al. Among authors: yanada m. Int J Hematol. 2005 Aug;82(2):85-92. doi: 10.1532/IJH97.05066. Int J Hematol. 2005. PMID: 16146837 Review.
135 results